Ally Bridge Group (Ny) LLC Aadi Bioscience, Inc. Transaction History
Ally Bridge Group (Ny) LLC
- $76.1 Million
- Q1 2025
A detailed history of Ally Bridge Group (Ny) LLC transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Ally Bridge Group (Ny) LLC holds 817,939 shares of AADI stock, worth $1.4 Million. This represents 1.91% of its overall portfolio holdings.
Number of Shares
817,939
Previous 817,939
-0.0%
Holding current value
$1.4 Million
Previous $2.58 Million
43.69%
% of portfolio
1.91%
Previous 2.93%
Shares
3 transactions
Others Institutions Holding AADI
# of Institutions
55Shares Held
32.4MCall Options Held
2.6KPut Options Held
2.1K-
Qvt Financial LP New York, NY4.52MShares$7.72 Million0.85% of portfolio
-
Orbimed Advisors LLC San Diego, CA4.17MShares$7.12 Million0.23% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.7MShares$6.33 Million0.29% of portfolio
-
Acuta Capital Partners, LLC Belmont, CA3.41MShares$5.83 Million11.51% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.85MShares$4.87 Million0.08% of portfolio
About Aadi Bioscience, Inc.
- Ticker AADI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,016,800
- Market Cap $35.9M
- Description
- Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...